Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S et al (2006)
Community subcutaneous protocols typically use 250 mcg to 1.5 mg per day from a reconstituted 5 mg vial
Olivia previously wrote for New York Magazines The Cut, PS (formerly POPSUGAR), and Salon, where she also did on-camera interviews with celebrity guests
It is a dual agonist, activating both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor simultaneously
Suspected side effects from any medicine, including trial drugs, should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk